Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division
Daniel Palmacci joins Lonza as President of the Cell & Gene Division and member of the Executive Committee Daniel will c…
Daniel Palmacci joins Lonza as President of the Cell & Gene Division and member of the Executive Committee Daniel will c…
Proteros biostructures GmbH today announced that the Company's Supervisory board had appointed Dave Lemus, previously a…
. Chief Scientific Officer Prof Dolores Schendel appointed new Chief Executive Officer of Medigene AG Dave Lemus appoi…
AYOXXA Biosystems GmbH, an international biotechnology company, announced that Dr. Gerald Möller has joined the company'…
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) and Immatics Biotechnologies GmbH announced today a…
On 6 May 2014, decision makers from the biopharmaceutical and medtech industries gathered in Munich with leading scienti…
On 6 May 2014, decision makers from the biopharmaceutical and medtech industries gathered in Munich with leading scienti…
Biametrics GmbH and MorphoSys AG today announce their intention to further collaborate in the area of high-throughput an…
Definiens AG, the leader in image analysis for Digital Pathology, today announced that Dr. Gerald Möller, has joined the…
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing therapeutic vaccines that are activ…